A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis
Top Cited Papers
Open Access
- 1 September 2006
- Vol. 55 (9), 1255-1262
- https://doi.org/10.1136/gut.2005.081794
Abstract
Background and aims: Immunosuppressive therapy with intravenous ciclosporin is an alternative treatment option to total colectomy for patients with ulcerative colitis (UC), while the benefits of oral administration of tacrolimus are not well defined and are based on reports of several uncontrolled studies. Methods: Patients with refractory active UC were randomly assigned to a high trough concentration (10–15 ng/ml) group (HT group) (n = 21), low trough concentration (5–10 ng/ml) group (LT group) (n = 22), or placebo group (n = 20). Patients received an initial oral dose of 0.05 mg/kg tacrolimus or placebo twice daily. Efficacy was evaluated in 60 patients based on a disease activity index (DAI) score. Fifty eight patients had additional treatment with tacrolimus and were evaluated for efficacy in a 10 week open label extension. Results: An improvement in DAI score (⩾4 points, all categories improved) was observed for 68.4% of cases in the HT group compared with 10.0% in the placebo group (pConclusions: Our findings demonstrate dose dependent efficacy and safety of oral tacrolimus for remission-induction therapy of refractory UC. The optimal target range appears to be 10–15 ng/ml in terms of efficacy with two week therapy.Keywords
This publication has 30 references indexed in Scilit:
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisThe New England Journal of Medicine, 2005
- Infliximab for acute, not steroid-refractory ulcerative colitisEuropean Journal of Gastroenterology & Hepatology, 2004
- Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantationPediatric Nephrology, 2002
- Oral tacrolimus treatment of severe colitis in childrenThe Journal of Pediatrics, 2000
- Combination Therapy with Oral Tacrolimus (FK506) and Azathioprine or 6-Mercaptopurine for Treatment-Refractory Crohnʼs Disease Perianal FistulaeInflammatory Bowel Diseases, 1999
- Wide Variation in Lymphocyte Steroid Sensitivity Among Healthy Human VolunteersJournal of Clinical Endocrinology & Metabolism, 1999
- Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid TherapyThe New England Journal of Medicine, 1994
- Coated Oral 5-Aminosalicylic Acid Therapy for Mildly to Moderately Active Ulcerative ColitisThe New England Journal of Medicine, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1987